| 1920 |
CEES Exposure |
NM |
HMOX1 |
UP |
Case-Control |
CEES Exposure |
CEES Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Interleukin 6 (IL-6) |
Transcript |
0 |
0 |
Real-time PCR |
NM |
| 2389 |
CEES Exposure |
NM |
MT1A |
UP |
Case-Control |
CEES Exposure |
CEES Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
interleukin 1 beta IL1B |
Transcript |
0 |
0 |
Real-time PCR |
NM |
| 3010 |
CEES Exposure |
NM |
TP53 |
UP |
Case-Control |
CEES Exposure |
CEES Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Interleukin 6 (IL-6) |
Transcript |
0 |
0 |
Real-time PCR |
NM |
| 3267 |
CEES Exposure |
NM |
IL1B |
UP |
Case-Control |
CEES Exposure |
CEES Exposure |
<0.001 |
|
in vitro |
Homo sapiens |
interleukin 1 beta IL1B |
Transcript |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3268 |
CEES Exposure |
NM |
IL6 |
UP |
Case-Control |
CEES Exposure |
CEES Exposure |
<0.001 |
|
in vitro |
Homo sapiens |
Interleukin 6 (IL-6) |
Transcript |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3274 |
CEES Exposure |
NM |
IL10 |
UP |
Case-Control |
CEES Exposure |
CEES Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Interleukin-10 IL10 |
Transcript |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 3275 |
CEES Exposure |
NM |
IL1B |
DOWN |
Case-Control |
CEES Exposure |
CEES Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
interleukin 1 beta IL1B |
Transcript |
0 |
0 |
Real-time PCR |
NM |
| 3276 |
CEES Exposure |
NM |
IL6 |
DOWN |
Case-Control |
CEES Exposure |
CEES Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Interleukin 6 (IL-6) |
Transcript |
0 |
0 |
Real-time PCR |
NM |
| 3277 |
CEES Exposure |
NM |
IL10 |
UP |
Case-Control |
CEES Exposure |
CEES Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Interleukin-10 IL10 |
Transcript |
0 |
0 |
Real-time PCR |
NM |
| 3278 |
CEES Exposure |
NM |
SOD1 |
UP |
Case-Control |
CEES Exposure |
CEES Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
interleukin 1 beta IL1B |
Transcript |
0 |
0 |
Real-time PCR |
NM |
| 3279 |
CEES Exposure |
NM |
BCL2 |
UP |
Case-Control |
CEES Exposure |
CEES Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Interleukin 6 (IL-6) |
Transcript |
0 |
0 |
Real-time PCR |
NM |
| 3280 |
CEES Exposure |
NM |
BAX |
UP |
Case-Control |
CEES Exposure |
CEES Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Interleukin 6 (IL-6) |
Transcript |
0 |
0 |
Real-time PCR |
NM |
| 4054 |
CEES Exposure |
NM |
reactive oxygen species |
DOWN |
Case-Control |
CEES Exposure |
CEES Exposure |
<0.001 |
|
in vitro |
Homo sapiens |
Reactive Oxygen Species |
Metabolite |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 4055 |
CEES Exposure |
NM |
reactive oxygen species |
DOWN |
Case-Control |
CEES Exposure |
CEES Exposure |
<0.001 |
|
in vitro |
Homo sapiens |
Reactive Oxygen Species |
Metabolite |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 4056 |
CEES Exposure |
NM |
reactive oxygen species |
DOWN |
Case-Control |
CEES Exposure |
CEES Exposure |
<0.001 |
|
in vitro |
Homo sapiens |
Reactive Oxygen Species |
Metabolite |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 4057 |
CEES Exposure |
NM |
reactive oxygen species |
DOWN |
Case-Control |
CEES Exposure |
CEES Exposure |
<0.001 |
|
in vitro |
Homo sapiens |
Reactive Oxygen Species |
Metabolite |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 4058 |
CEES Exposure |
NM |
reactive oxygen species |
DOWN |
Case-Control |
CEES Exposure |
CEES Exposure |
<0.01 |
|
in vitro |
Homo sapiens |
Reactive Oxygen Species |
Metabolite |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 4059 |
CEES Exposure |
NM |
reactive oxygen species |
DOWN |
Case-Control |
CEES Exposure |
CEES Exposure |
<0.05 |
|
in vitro |
Homo sapiens |
Reactive Oxygen Species |
Metabolite |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 4061 |
CEES Exposure |
NM |
reactive oxygen species |
NC |
Case-Control |
Untreated cells |
CEES Exposure |
NM |
|
in vitro |
Homo sapiens |
Reactive Oxygen Species |
Metabolite |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 4062 |
CEES Exposure |
NM |
reactive oxygen species |
NC |
Case-Control |
CEES Exposure |
CEES Exposure |
NM |
|
in vitro |
Homo sapiens |
Reactive Oxygen Species |
Metabolite |
0 |
0 |
Enzyme-linked immunosorbent assay (ELISA) |
NM |
| 4917 |
CEES Exposure |
NM |
necrosis |
DOWN |
Case-Control |
CEES Exposure |
CEES Exposure |
<0.001 |
|
in vitro |
Homo sapiens |
necrosis |
Phenotype |
0 |
0 |
Flow cytometry |
NM |
| 4918 |
CEES Exposure |
NM |
necrosis |
NC |
Case-Control |
Untreated cells |
CEES Exposure |
NM |
|
in vitro |
Homo sapiens |
necrosis |
Phenotype |
0 |
0 |
Flow cytometry |
NM |
| 4919 |
CEES Exposure |
NM |
necrosis |
NC |
Case-Control |
CEES Exposure |
CEES Exposure |
NM |
|
in vitro |
Homo sapiens |
necrosis |
Phenotype |
0 |
0 |
Flow cytometry |
NM |
| 4920 |
CEES Exposure |
NM |
necrosis |
NC |
Case-Control |
CEES Exposure |
CEES Exposure |
NM |
|
in vitro |
Homo sapiens |
necrosis |
Phenotype |
0 |
0 |
Flow cytometry |
NM |
| 4921 |
CEES Exposure |
NM |
necrosis |
NC |
Case-Control |
CEES Exposure |
CEES Exposure |
NM |
|
in vitro |
Homo sapiens |
necrosis |
Phenotype |
0 |
0 |
Flow cytometry |
NM |
| 4922 |
CEES Exposure |
NM |
necrosis |
NC |
Case-Control |
CEES Exposure |
CEES Exposure |
NM |
|
in vitro |
Homo sapiens |
necrosis |
Phenotype |
0 |
0 |
Flow cytometry |
NM |
| 4923 |
CEES Exposure |
NM |
necrosis |
NC |
Case-Control |
CEES Exposure |
CEES Exposure |
NM |
|
in vitro |
Homo sapiens |
necrosis |
Phenotype |
0 |
0 |
Flow cytometry |
NM |
| 4924 |
CEES Exposure |
NM |
necrosis |
NC |
Case-Control |
CEES Exposure |
CEES Exposure |
NM |
|
in vitro |
Homo sapiens |
necrosis |
Phenotype |
0 |
0 |
Flow cytometry |
NM |
| 5331 |
CEES Exposure |
NM |
apoptosis |
DOWN |
Case-Control |
CEES Exposure |
CEES Exposure |
<0.001 |
|
in vitro |
Homo sapiens |
Apoptosis |
Phenotype |
0 |
0 |
Flow cytometry |
NM |
| 5332 |
CEES Exposure |
NM |
apoptosis |
NC |
Case-Control |
Untreated cells |
CEES Exposure |
NM |
|
in vitro |
Homo sapiens |
Apoptosis |
Phenotype |
0 |
0 |
Flow cytometry |
NM |
| 5333 |
CEES Exposure |
NM |
apoptosis |
NC |
Case-Control |
CEES Exposure |
CEES Exposure |
NM |
|
in vitro |
Homo sapiens |
Apoptosis |
Phenotype |
0 |
0 |
Flow cytometry |
NM |
| 5334 |
CEES Exposure |
NM |
apoptosis |
NC |
Case-Control |
CEES Exposure |
CEES Exposure |
NM |
|
in vitro |
Homo sapiens |
Apoptosis |
Phenotype |
0 |
0 |
Flow cytometry |
NM |
| 5335 |
CEES Exposure |
NM |
apoptosis |
NC |
Case-Control |
CEES Exposure |
CEES Exposure |
NM |
|
in vitro |
Homo sapiens |
Apoptosis |
Phenotype |
0 |
0 |
Flow cytometry |
NM |
| 5336 |
CEES Exposure |
NM |
apoptosis |
NC |
Case-Control |
CEES Exposure |
CEES Exposure |
NM |
|
in vitro |
Homo sapiens |
Apoptosis |
Phenotype |
0 |
0 |
Flow cytometry |
NM |
| 5337 |
CEES Exposure |
NM |
apoptosis |
NC |
Case-Control |
CEES Exposure |
CEES Exposure |
NM |
|
in vitro |
Homo sapiens |
Apoptosis |
Phenotype |
0 |
0 |
Flow cytometry |
NM |
| 5338 |
CEES Exposure |
NM |
apoptosis |
NC |
Case-Control |
CEES Exposure |
CEES Exposure |
NM |
|
in vitro |
Homo sapiens |
Apoptosis |
Phenotype |
0 |
0 |
Flow cytometry |
NM |
| 5339 |
CEES Exposure |
NM |
apoptosis |
DOWN |
Case-Control |
CEES Exposure |
CEES Exposure |
<0.001 |
|
in vitro |
Homo sapiens |
Apoptosis |
Phenotype |
0 |
0 |
Flow cytometry |
NM |
| 5340 |
CEES Exposure |
NM |
apoptosis |
NC |
Case-Control |
Untreated cells |
CEES Exposure |
NM |
|
in vitro |
Homo sapiens |
Apoptosis |
Phenotype |
0 |
0 |
Flow cytometry |
NM |
| 5341 |
CEES Exposure |
NM |
apoptosis |
NC |
Case-Control |
CEES Exposure |
CEES Exposure |
NM |
|
in vitro |
Homo sapiens |
Apoptosis |
Phenotype |
0 |
0 |
Flow cytometry |
NM |
| 5342 |
CEES Exposure |
NM |
apoptosis |
NC |
Case-Control |
CEES Exposure |
CEES Exposure |
NM |
|
in vitro |
Homo sapiens |
Apoptosis |
Phenotype |
0 |
0 |
Flow cytometry |
NM |
| 5343 |
CEES Exposure |
NM |
apoptosis |
NC |
Case-Control |
CEES Exposure |
CEES Exposure |
NM |
|
in vitro |
Homo sapiens |
Apoptosis |
Phenotype |
0 |
0 |
Flow cytometry |
NM |
| 5344 |
CEES Exposure |
NM |
apoptosis |
NC |
Case-Control |
CEES Exposure |
CEES Exposure |
NM |
|
in vitro |
Homo sapiens |
Apoptosis |
Phenotype |
0 |
0 |
Flow cytometry |
NM |
| 5345 |
CEES Exposure |
NM |
apoptosis |
NC |
Case-Control |
CEES Exposure |
CEES Exposure |
NM |
|
in vitro |
Homo sapiens |
Apoptosis |
Phenotype |
0 |
0 |
Flow cytometry |
NM |
| 5346 |
CEES Exposure |
NM |
apoptosis |
NC |
Case-Control |
CEES Exposure |
CEES Exposure |
NM |
|
in vitro |
Homo sapiens |
Apoptosis |
Phenotype |
0 |
0 |
Flow cytometry |
NM |